# Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI

> **NCT00488761** · PHASE4 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 50 (actual)

## Conditions studied

- Skin Diseases, Infectious

## Interventions

- **DRUG:** Tigecycline

## Key facts

- **NCT ID:** NCT00488761
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2007-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00488761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00488761, "Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00488761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*